NCT02311296 is a clinical trial in Pneumonia, sponsored by University of Tennessee, Chattanooga.

Who is sponsoring NCT02311296?

NCT02311296 is sponsored by University of Tennessee, Chattanooga.

Is NCT02311296 still recruiting?

NCT02311296 is currently withdrawn. Last updated 25 November 2020.

Last reviewed 2020-11-25 · How we verify

NCT02311296

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Reduced Ventilator-Free Days and Bacterial Colonization of Sub-Glottic Secretions

Withdrawn Last updated 25 November 2020

What this trial tests

trial in Pneumonia. Withdrawn.

Timeline

2 November 2020

Primary endpoint
2 November 2020

2 November 2020

Quick facts

Lead sponsor	University of Tennessee, Chattanooga
Status	Withdrawn
Study type	OBSERVATIONAL
Start date	2 November 2020
Primary completion	2 November 2020
Estimated completion	2 November 2020
Sites	1 location across United States

Conditions studied

Pneumonia — all drugs for Pneumonia →

Sponsor

University of Tennessee, Chattanooga

Who can join

18 and older, any sex, with Pneumonia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Ventilator associated pneumonia (VAP) is common problem among ICU patients and major source of infection among patients receiving mechanical ventilation. Patients on mechanical ventilation accumulate secretion leading to aspiration of infected secretions. Using new generation endotracheal tube (Hi-Lo tube) can reduce the incidence of VAP.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pneumonia

Currently open trials in the same condition.

NCT07453966 — Efficacy and Safety of Intrapulmonary Percussive Ventilation in Patients With Pulmonary Infection Receiving Invasive Mec · NA · recruiting
NCT07251465 — A Study to Learn How Effective is PCV20 to Help Stop Adults Who Have a Higher Chance of Getting Pneumonia · active not recruiting
NCT07311343 — Oral Hygiene and Prophylactic Antibiotics to Prevent Intracerebral Hemorrhage Associated Pneumonia · Phase 4 · recruiting
NCT07298889 — High PEEP in Noninvasive Ventilation Patients With Pneumonia or ARDS · NA · recruiting
NCT06911658 — Infectious Complications After Esophagectomy · recruiting

Other University of Tennessee, Chattanooga trials

Trials by the same sponsor.

NCT00793013 — Airway Pressure Release Ventilation (APRV) Compared to ARDSnet Ventilation · Phase 2 · withdrawn
NCT04118777 — Postoperative Narcotic Use After Laparoscopic Gynecologic Surgery · NA · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02311296 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Tennessee, Chattanooga
Last refreshed: 25 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02311296.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing